Ozempic
NDC 0169-4130, semaglutide, injection, solution, from Novo Nordisk Pharmaceutical Industries, LP.
- Product NDC
- 0169-4130
- Status
- Listed
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209637
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-4130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SEMAGLUTIDE1.34 mg/mL
Pharmacologic classes
GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-4130-13 | 00169413013 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-4130-13) / 3 mL in 1 SYRINGE, PLASTIC (0169-4130-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/adec4fd2-6858-4c99-91d4-531f5f2a2d79NADAC price for package 00169413013
GET /v1/drugs/nadac/00169413013
Use it
Look up 0169-4130 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-4130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-4130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.